IMOS vs. AVNS
IMOS (ChipMOS TECHNOLOGIES INC.) and AVNS (Avanos Medical, Inc.) are both stocks. IMOS operates in Semiconductors (Technology), while AVNS operates in Medical Devices (Healthcare). Over the past 10 years, IMOS returned 16.10%/yr vs -3.20%/yr for AVNS. Their 0.18 correlation means their historical movements had little consistent relationship.
Performance
IMOS vs. AVNS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IMOS achieves a 62.07% return, which is significantly lower than AVNS's 122.53% return. Over the past 10 years, IMOS has outperformed AVNS with an annualized return of 16.10%, while AVNS has yielded a comparatively lower -3.20% annualized return.
IMOS
- 1D
- 0.74%
- 1M
- -25.86%
- 6M
- 29.33%
- YTD
- 62.07%
- 1Y
- 184.65%
- 3Y*
- 32.16%
- 5Y*
- 10.61%
- 10Y*
- 16.10%
- ALL TIME*
- 5.39%
AVNS
- 1D
- 0.00%
- 1M
- 0.24%
- 6M
- 87.61%
- YTD
- 122.53%
- 1Y
- 127.60%
- 3Y*
- 0.81%
- 5Y*
- -8.02%
- 10Y*
- -3.20%
- ALL TIME*
- -2.29%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $16.42M | $17.44M | $26.62M | |
| $6.65M | $8.96M | $7.58M |
IMOS vs. AVNS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IMOS ChipMOS TECHNOLOGIES INC. | 62.07% | 64.28% | -27.86% | 34.76% | -32.61% | 49.82% | 12.33% | 38.76% | -3.73% | 28.71% |
AVNS Avanos Medical, Inc. | 122.53% | -29.46% | -29.02% | -17.11% | -21.95% | -24.43% | 36.14% | -24.76% | -3.01% | 24.88% |
Correlation
The correlation between IMOS and AVNS is 0.07, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.07 |
Correlation (3Y) Balances recent behavior with more history. | 0.15 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.17 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.18 |
Correlation (All Time) Calculated using the full available price history since Oct 21, 2014 | 0.18 |
The correlation between IMOS and AVNS shifts across timeframes, from 0.07 (1 year) to 0.18 (all time), reflecting how their relationship changes across market environments.
Fundamentals
IMOS:
$1.66B
AVNS:
$1.17B
IMOS:
NT$9.58
AVNS:
-$2.24
IMOS:
2.88
AVNS:
1.08
IMOS:
NT$18.75B
AVNS:
$715.90M
IMOS:
NT$2.12B
AVNS:
$353.40M
IMOS:
-NT$130.72M
AVNS:
-$29.60M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IMOS vs. AVNS — Risk / Return Rank
IMOS
AVNS
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
IMOS vs. AVNS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ChipMOS TECHNOLOGIES INC. (IMOS) and Avanos Medical, Inc. (AVNS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IMOS | AVNS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.03 | ||
| Sortino ratioReturn per unit of downside risk | -0.97 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.62 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | 4.63 | 6.61 | -1.97 |
| Martin ratioReturn relative to average drawdown | 15.21 | 14.84 | +0.37 |
Loading charts...
Drawdowns
IMOS vs. AVNS - Drawdown Comparison
The maximum IMOS drawdown since its inception was -98.76%, which is greater than AVNS's maximum drawdown of -86.39%. Use the drawdown chart below to compare losses from any high point for IMOS and AVNS.
Loading charts...
Drawdown Indicators
| IMOS | AVNS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.76% | -86.39% | -12.37% |
Max Drawdown (1Y)Largest decline over 1 year | -39.78% | -16.19% | -23.59% |
Max Drawdown (3Y)Largest decline over 3 years | -55.46% | -59.94% | +4.48% |
Max Drawdown (5Y)Largest decline over 5 years | -62.26% | -73.22% | +10.96% |
Max Drawdown (10Y)Largest decline over 10 years | -62.26% | -86.39% | +24.13% |
Current DrawdownCurrent decline from peak | -37.45% | -65.60% | +28.15% |
Average DrawdownAverage peak-to-trough decline | -60.21% | -47.25% | -12.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.10% | 7.44% | +4.66% |
Volatility
IMOS vs. AVNS - Volatility Comparison
ChipMOS TECHNOLOGIES INC. (IMOS) has a higher volatility of 30.57% compared to Avanos Medical, Inc. (AVNS) at 1.66%. This indicates that IMOS's price experiences larger fluctuations and is considered to be riskier than AVNS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IMOS | AVNS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.57% | 1.66% | +28.91% |
Volatility (6M)Calculated over the trailing 6-month period | 62.73% | 55.78% | +6.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.47% | 77.12% | -1.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.46% | 47.85% | -2.39% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.80% | 44.55% | -3.75% |
Dividends
IMOS vs. AVNS - Dividend Comparison
IMOS's dividend yield for the trailing twelve months is around 1.65%, while AVNS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVNS Avanos Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IMOS ChipMOS TECHNOLOGIES INC. | 1.65% | 2.77% | 5.90% | 5.52% | 13.62% | 4.46% | 3.84% | 2.61% | 0.80% | 3.49% | 7.28% | 0.71% |
Financials
IMOS vs. AVNS - Financials Comparison
This section allows you to compare key financial metrics between ChipMOS TECHNOLOGIES INC. and Avanos Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
IMOS vs. AVNS - Profitability Comparison
IMOS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, ChipMOS TECHNOLOGIES INC. reported a gross profit of 30.20M and revenue of 219.23M. Therefore, the gross margin over that period was 13.8%.
AVNS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Avanos Medical, Inc. reported a gross profit of 94.20M and revenue of 182.20M. Therefore, the gross margin over that period was 51.7%.
IMOS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, ChipMOS TECHNOLOGIES INC. reported an operating income of 15.92M and revenue of 219.23M, resulting in an operating margin of 7.3%.
AVNS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Avanos Medical, Inc. reported an operating income of 8.90M and revenue of 182.20M, resulting in an operating margin of 4.9%.
IMOS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, ChipMOS TECHNOLOGIES INC. reported a net income of 15.96M and revenue of 219.23M, resulting in a net margin of 7.3%.
AVNS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Avanos Medical, Inc. reported a net income of 5.10M and revenue of 182.20M, resulting in a net margin of 2.8%.
Frequently Asked Questions
IMOS and AVNS have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IMOS has higher volatility (30.57%) compared to AVNS (1.66%). In terms of maximum drawdown, IMOS dropped -98.76% vs AVNS's -86.39%.
IMOS currently has the higher Sharpe Ratio (2.44 vs 1.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IMOS and AVNS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer